Upload Avatar (500 x 500)
Ji Zhou Wang
wangjoe@ustc.edu.cn
Chinese, English
Anhui
University of Science and Technology of China
Mayo Clinic College of Medicine
  • 2003/09–2011/06 PhD in Surgery: Harbin Medical University
  • First Prize in the Ministry of Education's Scientific Research Outstanding Achievement Award
  • First Prize in Heilongjiang Province Medical and Health New Technology Application Award
  • Outstanding Health Talent of Anhui Province
  • Current - First Affiliated Hospital of University of Science and Technology of China - Chief of General Surgery
  • Visiting Scholar - University of Sydney, Westmead Hospital and Royal Prince Alfred Hospital
  • First Prize in the Ministry of Education's Scientific Research Outstanding Achievement Award
  • First Prize in Heilongjiang Province Medical and Health New Technology Application Award
Liver Transplantation
Hepatobiliary Surgery
  • Tumour response following preoperative chemotherapy is affected by body mass index in patients with colorectal liver metastases., Song HC, Zhou HC, Gu P, Bao B, Sun Q, Mei TM, Cui W, Yao K, Yao HZ, Zhang SY, Wang YS, Song RP, Wang JZ., 2024
  • Clinical efficacy of avatrombopag and recombinant human thrombopoietin in the treatment of chronic liver disease-associated severe thrombocytopenia: A real-world study., Wang YS, Wang W, Zhang S, Zhang SY, Shen AZ, Wang W, Song HC, Yao HZ, Song RP, Meng FZ, Li L, Nashan B, Wang JZ, Liu LX., 2022
  • 《BCLC预后预测和治疗推荐策略,2022版》解读, 宋华传,王继洲., 2022
  • 结直肠癌肝转移手术切缘问题研究进展, 宋华传,王继洲., 2023
  • 多纳非尼辅助治疗肝细胞癌术后高危复发病人安全性和有效性初步研究, 张珅瑜,宋瑞鹏,王伟,尹大龙,王嘉,张树庚,蔡伟,王继洲,刘连新., 2023
  • 阿伐曲泊帕联合重组人血小板生成素和阿伐曲泊帕单药治疗慢性肝病相关重度血小板减少症的临床疗效, 王永帅,张赛,李磊,王伟,王伟,张珅瑜,宋华传,姚焕章,宋瑞鹏,刘连新,王继洲., 2022
  • 术前肝静脉剥夺术同期联合精准肝动脉化疗栓塞在原发性大肝癌二期切除中应用价值研究, 侯昌龙,王继洲,宋瑞鹏,许军,尹大龙,王嘉,张树庚,蔡伟,刘连新., 2022
  • 控制性低中心静脉压在高龄腹腔镜肝切除术中的应用, 王继洲,孟凡征,张赛,张珅瑜,刘连新,宋瑞鹏., 2021
Liver Transplantation Surgery Hepatobiliary Oncology Research Clinical Innovation Health Medicine

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.